aesthetic bureau logo
1300 858 711
contact us

Pico Defyne ROI

Aesthetic Bureau Pico Defyne Commercial viability

Pico Defyne commercial viability calculator.

Model treatment pricing, weekly volume, LTO, rental and ownership scenarios using your clinic's own assumptions.

Estimated price recovery—
Cash surplus / month—
Revenue / month—
Pico Defyne laser device

Business case first

Put in your numbers. See what has to be true.

Compare purchase, lease-to-own and short-term rental, without assuming the diary is full from day one. This is an illustrative commercial planning tool, not a sales forecast.

Break-even clarityDemand realityAcquisition options
Pre-fill indicative prices to

Changing tiers replaces treatment prices only; your volume, package and enable/disable settings are preserved.

01

Your investment

Check device pricing, finance terms and inclusions with your Aesthetic Bureau consultant. All pre-filled figures are editable assumptions, shown in A$ excluding GST.

A$

Guide: A$120,000 base package; test A$130,000 for the full handpiece set. Confirm actual inclusions and pricing with AB.

How are you acquiring it?
A$/ week
months
A$
A$
A$
A$

Labour is a loaded delivery cost; overhead includes only amounts attributable to Pico Defyne. Avoid double-counting existing clinic expenses.

02

Your treatment mix

Only Pico Defyne-relevant treatments appear below. Toggle treatments in either the menu or their cards. Pricing and weekly volumes are editable.

Treatment menu strategy

Model a menu, not one hero treatment.

Test a blended Pico Defyne treatment menu across tattoo, pigment, rejuvenation and texture demand rather than expecting one category to carry the entire investment.

Choose which treatments contribute to the model. Disabled treatments can still be edited, but add no revenue or volume.

03

Demand & ramp-up

Weekly volumes above are full-demand targets. Scenarios scale them, then a gradual utilisation ramp is applied to the cash-flow forecast.

Sustained demand scenario

Realistic models 70% of your entered treatment targets.

%
months

About these figures. Indicative, editable treatment prices and demand inputs are illustrative modelling assumptions, not verified price recommendations or clinical claims. Treatments must be selected according to device specifications, practitioner training, patient suitability and applicable Australian advertising requirements.

Financial definitions. “Cash surplus” means projected device-level operating cash flow after modelled costs and acquisition payments where applicable; it is not whole-clinic accounting net profit. Ownership price recovery is a notional device-value benchmark based on pre-financing operating contribution, so it is not an LTO repayment period or a forecast of actual return on equity. Five-year position for LTO counts payments during the entered term; outright purchase deducts the upfront device price. Rental is assessed only over the specified rental term, as the device is returned.

All figures exclude GST, income tax, financing deposits/balloons, bad debts, lost appointments, downtime, upgrades and resale value. Assumes 52 weeks / year, no inflation, no growth after ramp beyond target demand and constant treatment mix. Seek professional financial advice before an investment decision.

Shopping Cart